SCOPUS 정보 검색 플랫폼

Volumn 89, Issue 5, 2002, Pages 647-650

Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions

(6) Kabbani, Samer S a Aggarwal, Atul a Terrien, Edward F a DiBattiste, Peter M b Sobel, Burton E a Schneider, David J a

a UNIVERSITY OF VERMONT (United States)

b MERCK RESEARCH LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; TIROFIBAN;

BLOOD; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INHIBITION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; IATROGENIC DISEASE; MALE; ONSET AGE; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0036498633 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9149(01)02319-0 Document Type: Article

Times cited : (95)

References (18)

1
- 0035838355
- Platelet reactivity characterized prospectively: A determinant of outcome 90 days after percutaneous coronary intervention
- (2001) Circulation , vol.104 , pp. 181-186
- Kabbani, S.S.¹ Watkins, M.W.² Ashikaga, T.³ Terrien, E.F.⁴ Holoch, P.A.⁵ Sobel, B.E.⁶ Schneider, D.J.⁷

2
- 2242477091
- Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation
- (1994) N Engl J Med , vol.330 , pp. 956-961

3
- 1842369101
- Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous revascularization
- (1997) N Engl J Med , vol.336 , pp. 1689-1696

4
- 0028930680
- Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention
- IMPACT Investigators
- (1995) Circulation , vol.91 , pp. 2151-2157
- Tcheng, J.E.¹ Harrington, R.A.² Kottke-Marchant, K.³ Kleiman, N.S.⁴ Ellis, S.G.⁵ Kereiakes, D.J.⁶ Mick, M.J.⁷ Navetta, F.I.⁸ Smith, J.E.⁹ Worley, S.J.¹⁰

5
- 0000656559
- Randomised placebo-controlled trial of the effect of integrilin on complications of PTCA: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II
- (1997) Lancet , vol.349 , pp. 1422-1428

6
- 9044234402
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty
- (1996) J Am Coll Cardiol , vol.27 , pp. 536-542
- Kereiakes, D.J.¹ Kleiman, N.S.² Ambrose, J.³ Chen, M.⁴ Rodriquez, S.⁵ Palabrica, T.⁶ Herrmann, H.C.⁷ Sutton, J.M.⁸ Weaver, W.D.⁹ McKee, D.B.¹⁰ Fitzpatrick, V.¹¹ Sax, F.L.¹²

7
- 0343376106
- Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
- (1997) Circulation , vol.96 , pp. 1445-1453

8
- 0035897706
- Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: The ESPRIT trial: A randomized controlled trial
- (2001) JAMA , vol.285 , pp. 2468-2473
- O'Shea, J.C.¹ Hafley, G.E.² Greenberg, S.³ Hasselblad, V.⁴ Lorenz, T.J.⁵ Kitt, M.M.⁶ Strony, J.⁷ Tcheng, J.E.⁸

9
- 0035927988
- Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
- (2001) N Engl J Med , vol.344 , pp. 1888-1894
- Topol, E.J.¹ Moliterno, D.J.² Herrmann, H.C.³ Powers, E.R.⁴ Grines, C.L.⁵ Cohen, D.J.⁶ Cohen, E.A.⁷ Bertrand, M.⁸ Neumann, F.J.⁹ Stone, G.W.¹⁰ DiBattiste, P.M.¹¹ Demopoulos, L.¹²

10
- 0035040324
- Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab
- (2001) Coron Artery Dis , vol.12 , pp. 245-253
- Holmes, M.B.¹ Kabbani, S.S.² Terrien, C.M.³ Watkins, M.W.⁴ Sobel, B.E.⁵ Schneider, D.J.⁶

11
- 0033960084
- Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists
- (2000) J Thromb Thrombolysis , vol.9 , pp. 23-28
- Rebello, S.S.¹ Huang, J.² Faul, J.D.³ Lucchesi, B.R.⁴

12
- 0029858330
- Blood clotting in minimally altered whole blood
- (1996) Blood , vol.88 , pp. 3432-3445
- Rand, M.D.¹ Lock, J.B.² Veer, C.V.³ Gaffney, D.P.⁴ Mann, K.G.⁵

13
- 0029998797
- Optimally functional fluorescein isothiocyanate-labeled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation
- (1996) Br J Haematol , vol.93 , pp. 204-214
- Xia, V.¹ Wong, T.² Liu, Q.³ Kasirer-Friede, A.⁴ Brown, E.⁵ Frojmovic, M.M.⁶

14
- 0035122593
- Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin
- (2001) Thromb Haemost , vol.85 , pp. 309-313
- Schneider, D.J.¹ Baumann, P.Q.² Holmes, M.B.³ Taatjes, D.J.⁴ Sobel, B.E.⁵

15
- 0021965983
- A new murine monoclonal antibody reports activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex
- (1985) J Clin Invest , vol.76 , pp. 101-108
- Coller, B.S.¹

16
- 0033374089
- Tirofiban (Aggrastat®)
- (1999) Cardiovasc Drug Rev , vol.17 , pp. 199-224
- Cook, J.J.¹ Bednar, B.² Lynch, J.J.³ Gould, R.J.⁴ Egbertson, M.S.⁵ Halczenko, W.⁶ Duggan, M.E.⁷ Hartman, G.D.⁸ Lo, M.W.⁹ Murphy, G.M.¹⁰

17
- 0035312338
- Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
- (2001) J Am Coll Cardiol , vol.37 , pp. 1323-1328
- Neumann, F.J.¹ Hochholzer, W.² Pogatsa-Murray, G.³ Schomig, A.⁴ Gawaz, M.⁵

18
- 0030664732
- Differential effects of anticoagulants on the activation of platelets ex vivo
- (1997) Circulation , vol.96 , pp. 2877-2883
- Schneider, D.J.¹ Tracy, P.B.² Mann, K.G.³ Sobel, B.E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.